Tammy Calhoun‐Davis
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Oncology top 2%
- Cancer Cells and Metastasis 12
- Molecular Biology top 5%
- FOXO transcription factor regulation 3
- Epigenetics and DNA Methylation 2
-
- Prostate Cancer Treatment and Research 7
- Cell Biology top 5%
-
- Immunotherapy and Immune Responses 4
-
- Cancer, Stress, Anesthesia, and Immune Response 2
- Journals
- Journal of Biological Chemistry (1 paper)Nature Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Tammy Calhoun‐Davis
17 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 1.3k
- Oncology 1.4k
- Molecular Biology 2.0k
- Pulmonary and Respiratory Medicine 745
- Cell Biology 224
Countries citing papers authored by Tammy Calhoun‐Davis
This map shows the geographic impact of Tammy Calhoun‐Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tammy Calhoun‐Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tammy Calhoun‐Davis more than expected).
Fields of papers citing papers by Tammy Calhoun‐Davis
This network shows the impact of papers produced by Tammy Calhoun‐Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tammy Calhoun‐Davis. The network helps show where Tammy Calhoun‐Davis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tammy Calhoun‐Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 75 | |
| 2 | 2016 | 42 | |
| 3 | 2016 | 148 | |
| 4 | 2016 | 96 | |
| 5 | 2016 | 45 | |
| 6 | 2016 | 18 | |
| 7 | 2013 | 10 | |
| 8 | 2012 | 243 | |
| 9 | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44breakdown → | 2011 | 1136 |
| 10 | 2011 | 42 | |
| 11 | 2011 | 302 | |
| 12 | 2009 | 30 | |
| 13 | 2009 | 280 | |
| 14 | 2008 | 181 | |
| 15 | 2008 | 31 | |
| 16 | 2007 | 279 | |
| 17 | 2007 | 38 |
About Tammy Calhoun‐Davis
Tammy Calhoun‐Davis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 17 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (12 papers), Prostate Cancer Treatment and Research (7 papers), Immunotherapy and Immune Responses (4 papers), FOXO transcription factor regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.4k citations) and Molecular Biology (2.0k citations). Tammy Calhoun‐Davis has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Dean G. Tang, Xin Chen, Lubna Patrawala, Collene Jeter, Can Liu, Hangwen Li, Bigang Liu, Sofia Honorio, Kevin Kelnar and Jason F. Wiggins. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.